Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy
- Salvatore Perrone
- , Andrea Corbingi
- , Calogero Vetro
- , Fanny Erika Palumbo
- , Paola Minetto
- , Carola Riva
- , Laura Cicconi
- , Chiara Vernarecci
- , Roberto Massimo Lemoli
- , Alessandro Pulsoni
- , Fabio Guolo
- S.M. Goretti Hospital
- Teaching Hospital of Paracelsus Medical University (PUM)
- Division of Hematology and Bone Marrow Transplant Unit
- Dipartimento di Oncologia ed Ematologia (DipOE)
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung